Company Profile
Rapid Micro Biosystems Stock Price, News & Analysis
- Ticker:
- RPID
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
2.01 USD (-1.95%)
Close
Last updated: July 13, 2026 at 00:00
102.13M USD
Market cap
Why the stock is moving
RPID is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Rapid Micro Biosystems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Rapid Micro Biosystems is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Rapid Micro Biosystems follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Rapid Micro Biosystems sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
- 03
Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis
ENLV · Source: Enlivex Therapeutics
- 04
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 05
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Rapid Micro Biosystems (RPID)?
Rapid Micro Biosystems (RPID) most recently closed at 2.01 USD, a -1.95% move versus the previous session.
What is the market cap of Rapid Micro Biosystems (RPID)?
Rapid Micro Biosystems currently has a market capitalization of 102.13M USD on BioPharmSignal.
What does Rapid Micro Biosystems do?
Rapid Micro Biosystems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is RPID stock listed?
Rapid Micro Biosystems (RPID) is associated with NASDAQ, United States, Biotechnology.
What is Rapid?
Rapid Micro Biosystems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Rapid Micro Biosystems targeting with Rapid?
Rapid Micro Biosystems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Micro?
Rapid Micro Biosystems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Biosystems?
Rapid Micro Biosystems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.